Skip to main content
S&P 5007,818.93+0.58%DOW51,521.28+0.49%NASDAQ27,599.89+0.45%BTC$85,520.00-0.35%ETH$2,697.04-0.63%GOLD$4,189.90+0.07%OIL$89.91+0.53%
Smart Investors Daily
SID Premium
SE

NASDAQ · SENS

Senseonics Holdings, Inc.

Healthcare · Medical - Devices

$9.96

Down-$0.35 (-3.39%)

Updated Oct 7, 2026, 7:00 AM

SID Score

5.6/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
289.23M
P/E ratio
-4.92
Dividend yield
0.00%
52-week range
$4.79 – $11.58
Volume
568.8K
Avg. volume
486.83K

Price performance · SENS

SENS price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 6, 2026

SENS closed at $9.96 after 21 trading sessions, up 6.75% for the selected period.

Last close
$9.96
Period change
+6.75%
Period low
$8.71
Period high
$10.34
Daily close
View OHLC price history
SENS OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 6, 2026$10.38$10.55$9.8707$9.96568.8K
Oct 5, 2026$9.83$10.36$9.5856$10.31709.56K
Oct 2, 2026$10.04$10.09$9.78$9.88705.95K
Oct 1, 2026$10.10$10.19$9.90$9.96606.44K
Sep 30, 2026$10.12$10.64$10.01$10.17922.47K
Sep 29, 2026$9.90$10.17$9.77$10.05606.99K
Sep 28, 2026$9.85$10.29$9.805$9.84566.65K
Sep 25, 2026$10.28$10.42$10.00$10.00569.76K
Sep 24, 2026$9.95$10.4775$9.95$10.34897.38K
Sep 23, 2026$10.04$10.06$9.73$9.975840.14K
Sep 22, 2026$9.80$10.06$9.52$10.06717.81K
Sep 21, 2026$9.60$9.80$9.34$9.78897.5K
Sep 18, 2026$9.43$9.665$9.24$9.581.72M
Sep 17, 2026$9.19$9.66$9.02$9.43990.86K
Sep 16, 2026$8.89$9.40$8.89$9.06739.24K
Sep 15, 2026$8.80$8.97$8.606$8.88436.09K
Sep 14, 2026$8.76$9.03$8.76$8.84567.46K
Sep 11, 2026$8.93$8.95$8.57$8.71395.17K
Sep 10, 2026$8.61$9.13$8.45$8.79452.52K
Sep 9, 2026$9.25$9.535$8.68$8.72768.61K
Sep 8, 2026$9.61$9.6406$9.23$9.33531.18K

Latest SENS news

The latest Smart Investors Daily articles mentioning SENS.

Stock researchCompany · Overview

SENS research

Overview

Company profile and research snapshot.

Company profile

Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$1.10
Implied upside
—
Analysts
—
SENS recent ratings
DateFirmRatingTarget
Jul 15, 2026MizuhoOutperform—
May 12, 2026HC Wainwright & Co.Buy—
May 11, 2026StifelHold—
Nov 6, 2025HC Wainwright & Co.Buy—
Nov 5, 2025BarclaysOverweight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 14, 2026

Senseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense® 365 with the iLet® Bionic Pancreas

Pairing year-long continuous glucose monitoring with automated insulin delivery to further simplify diabetes management for patients Brings Eversense 365 to the growing community of iLet Bionic Pancreas users Plan for commercial launch of the integrated system in Q4 2026 GERMANTOWN, Md., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), maker of the Eversense 365 Continuous Glucose Monitoring (CGM) System, the world’s first and only long-term, one-year implantable sens

Yahoo · Sep 10, 2026

Senseonics To Participate in Upcoming Institutional Investor Conferences

GERMANTOWN, Md., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in two upcoming investor conferences. Details on the Company’s participation appear below: Lake Street 10th Annual Big Ideas Growth Conference – September 10, 2026 (New York, NY)Management will host o

Benzinga · Aug 14, 2026

Jim Cramer Says Buy Carpenter Technology, Calls This IT Services Stock a 'Value Trap'

Cramer recommends buying Carpenter Technology (NYSE: CRS) and calls DXC Technology (NYSE: DXC) a value trap. Senseonics Holdings (NASDAQ: SENS) posts upbeat sales and Ubiquiti (NYSE: UI) reports worse-than-expected results. Hess Midstream (NYSE: HESM) is a winner while Zeta Global (NYSE: ZETA) announces a new CMO. UL Solutions (NYSE: ULS) is a potential buy and Coupang (NYSE: CPNG) is not recommended, but MercadoLibre (NASDAQ: MELI) and Amazon (NASDAQ: AMZN) are worth considering.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By